Half way through February, Suzlon looks a very different proposition to the company that started 2015, never mind the debt-wracked business of 12 months earlier that looked to have limited room for manoeuvre in any direction.
So far this year Suzlon has agreed the sale of its Germany based Senvion unit in a deal worth about $1.2bn, and today announced that Dilip Shanghvi – thetycoon who founded Sun Pharma, India’s biggest pharmaceutical group – will take a 23% stake in the company for $289m.
Shanghvi’s
